Navigation Links
Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
Date:7/8/2008

Conference Call Scheduled for 8:30 a.m. ET

ORANGE COUNTY, Calif., July 8 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC) announced today it will host a conference call on Friday, July 25, 2008, at 8:30 a.m. ET to discuss the company's second quarter 2008 results. Earnings will be released earlier that morning.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The call may be accessed by dialing (877) 516-3365 or (706) 679-3246 and asking for the Beckman Coulter conference call or reservation number 53822642.

There also will be a live webcast of the call. It will be accessible to all investors through Beckman Coulter's website at http://www.beckmancoulter.com. When accessing the webcast through the Beckman Coulter site, select "go to IR" under "Investor Relations" and find the call listed under "What's Ahead." The webcast will be archived on both websites for future on-demand replay.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating type lease payments, represent more than 78 percent of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Contact:

Allan D. Harris
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Upcoming Beckman Coulter Investor Events Second Half of 2008
2. Beckman Coulter to Present at Upcoming Healthcare Conferences
3. Beckman Coulter Announces First Quarter 2008 Results
4. Beckman Coulter Acquires Rights to Hepatitis C Virus
5. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
6. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
7. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
8. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell
9. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MESA, Calif. , July 24, 2014  Now ... close to home. Rehealth Regenerative Therapies , located ... athletes and other physically active people a new health ... Regardless of age, countless patients suffer from ... sport activities, such as muscle tears, torn rotator cuff, ...
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... biotechnology company in the emerging field of regenerative ... live webcast of a presentation to investors on ... 1:30 p.m. PDT.  The presentation will include an ... pipeline. To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, LLC ... with University College Hospital (UCH) Ibadan Board ... project to finance, design, construct, and operate and maintain ... Nigeria . Under the first of the 4-phase ... documents and funding applications. UCH Ibadan intends to finance ...
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2Nano-sized chip 'sniffs out' explosives far better than trained dogs 2
... 2008 at 9:30 a.m., SUNRISE, Fla., Aug. 1 ... Leonhardt, Chairman and CEO of,Bioheart, will present a corporate ... the Red Chip Investor Conference at the Marriott,Marquis in ... will be,available via the internet by visiting and registering ...
... Monitoring and ... Diagnostic System, ... ), announced it has entered into a non-binding letter of,intent ... a real-time wireless beat-to-beat, intelligent heart monitor and,diagnostic system, designed ...
... Holdings, a newly-formed,holding company that is the parent ... Diagnostics (CMDx), announced today that George Poste,D.V.M., Ph.D, ... with,the company, serving as Non-Executive Vice Chairman and ... of CMDx. Dr. Poste has,been a Director of ...
Cached Biology Technology:Bioheart, Inc. to Present at Red Chip Investor Conference in New York 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 3Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 4Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 5Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics 2Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics 3
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- The Geneva Healthcare ... cardiac devices, has cut emergency room wait times by ... Diego (UCSD) Medical Center, according to a recent study ... Emergency Departments are using the suite to access data ... or defibrillators. "Using Geneva,s technology platform we ...
(Date:7/24/2014)... (July 24, 2014) Scientists at The New ... one step closer to creating a viable cell ... own cells. , For the first time, ... lines from skin samples of patients with primary ... accelerated protocol to induce these stem cells into ...
(Date:7/24/2014)... animal species for food or commercial food sale, has ... the decline of many species of primates and other ... than half of the species being consumed are birds, ... not only the meat made available for sale but ... by hunters and brought to villages for consumption, we ...
Breaking Biology News(10 mins):UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... Delhi, IndiaThe Government of India,s Department of Biotechnology (DBT) ... III clinical trial of a rotavirus vaccine developed and ... at the International Symposium on Rotavirus Vaccines for IndiaThe ... excellent safety and efficacy profile. The clinical ...
... China, Australia and Japan today reports having sequenced and annotated ... have a powerful genetic system that repairs genetic defects, and ... than 86 percent of the nearly 27,000 genes of the ... and elsewhere as a symbol of spiritual purity and longevity. ...
... Ohio A study has identified microRNA-155 as a ... with acute myeloid leukemia that has normal-looking chromosomes under ... or CN-AML)., The study was led by researchers at ... G. James Cancer Hospital and Richard J. Solove Research ...
Cached Biology News:Rotavirus vaccine developed in India demonstrates strong efficacy 2Rotavirus vaccine developed in India demonstrates strong efficacy 3Rotavirus vaccine developed in India demonstrates strong efficacy 4Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 2Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 3Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 4Study identifies possible new acute leukemia marker, treatment target 2